Furthermore, the butyrate level in the plasma is negatively correlated with Aβ deposition in cognitively impaired individuals and butyrate decreases BBB permeability and IL-1β expression in LPS-induced AD mice (Marizzoni et al., 2020). Here, IL1B is linked to Alzheimer disease.